Back to today’s briefing

Story perspectives

FDA Layoffs Spark Concerns Over Drug Safety Oversight

7/7/2025

23 2

Summary

Story summary

The FDA is grappling with the fallout from laying off 3,500 employees, severely impacting its drug safety oversight. With low morale and rising political meddling, inspections and reviews are suffering. The agency's difficulty in retaining seasoned staff raises alarming questions about the safety of medications coming from abroad, leaving public health at risk.

1 of 1

Story summary

The FDA is grappling with the fallout from laying off 3,500 employees, severely impacting its drug safety oversight. With low morale and rising political meddling, inspections and reviews are suffering. The agency's difficulty in retaining seasoned staff raises alarming questions about the safety of medications coming from abroad, leaving public health at risk.